Enhancement of cocaine's abuse liability in methadone maintenance patients

Psychopharmacology

Volumn 123, Issue 1, 1996, Pages 15-25

  Preston, K L ^a,b   Sullivan, J T ^b   Strain, E C ^b   Bigelow, G E ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abuse liability; Cocaine; Cocaine abuse; Drug abuse; Drug interactions; Humans; Methadone; Opiates

Indexed keywords

COCAINE; METHADONE; PLACEBO;

ADULT; ARTICLE; BREATHING RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; METHADONE TREATMENT; MOOD; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; PUPIL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SKIN TEMPERATURE;

ADULT; BLOOD PRESSURE; BODY TEMPERATURE; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE; HEART RATE; HUMANS; METHADONE; RESPIRATION; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 0030034458     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246276     Document Type: Article

References (45)

1. Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, New York
2. Black JL, Dolan MP, Penk WE, Robinowitz R, DeFord HA (1987) The effect in increased cocaine use on drug treatment. Addict Behav 12:289-292
3. Blumberg H, Ikeda C (1978) Naltrexone, morphine and cocaine interactions in mice and rats. J Pharmacol Exp Ther 206:303-310
4. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR (1989) Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261:561-565
5. Condelli WS, Fairbank JA, Dennis MF, Rachal JV (1991) Cocaine use by clients in methadone programs: Significance, scope, and behavioral interventions. J Subst Abuse 8:203-212
6. Cooper JR (1989) Methadone treatment and acquired immunodeficiency syndrom JAMA 262:1664-1668
7. Cushman P (1988) Cocaine use in a population of drug abusers on methadone. Hosp Commun Psychiatry 39:1205-1207
8. Dole VP (1988) Implications of methadone maintenance for theories of narcotic addiction. JAMA 260:3025-3029
9. Downs DA (1979) Interactions of acetylmethadol or methadone with other drugs in rhesus monkeys. Pharmacol Biochem Behav 10:407-414
10. Fischman MW, Schuster CR (1980) Cocaine effects in sleep-deprived humans. Psychopharmacology 72:1-8
11. Foltin RW, Fischman MW (1992) The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Ther 261:623-632
12. Foltin RW, Fischman MW (1994) Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol 5:79-89
13. Forman LJ, Estilow S (1988) Cocaine influences beta-endorphin levels and release. Life Sci 43:309-315
14. Gottheil E, Sterling RC, Weinstein SP (1993) Diminished illicit drug use as a consequence of long-term methadone maintenance. J Addict Dis 12:45-57
15. Houdi AA, Bardo MT, Van Loon GR (1989) Opioid medication of cocaine-induced hyperactivity and reinforcement. Brain Res 497:195-198
16. Hunt DE, Strug DL, Goldsmith DS, Lipton DS, Spunt B, Truitt L, Robertson KA (1984) An instant shot of "Aah": cocaine use among methadone clients. J Psychoact Drugs 16:217-227
17. Kidorf M, Stitzer ML (1993a) Descriptive analysis of cocaine use of methadone patients. Drug Alcohol Depend 32:267-275
18. Kidorf M, Stitzer ML (1993b) Contingent access to methadone maintenance treatment: effects on cocaine use of mixed opiate-cocaine abusers. Exp Clin Psychopharmacol 1:200-206
19. Kolar AF, Brown BS, Weddington WW, Ball JC (1990) A treatment crisis: cocaine use by clients in methadone maintenance programs. J Subst Abuse Treat 7:101-107
20. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
21. Kosten TR, Rounsaville BJ, Kleber HD (1987a) A 2.5-year follow-up of cocaine use among treated opioid addicts. Arch Gen Psychiatry 44:281-284
22. Kosten TR, Kreek MJ, Swift C, Carney MK, Ferdinands L (1987b) Beta endorphin levels in CSF during methadone maintenance. Life Sci 41:1071-1076
23. Leander JD, Lucot JB (1977) Toxic interactions of stimulants, narcotics and narcotic antagonists. Res Commun Chem Pathol Pharmacol 17:255-264
24. Martin WR, Sloan JW, Sapiro JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245-258
25. Martin WR, Jasinski DR, Haertzen CA, Kay DC, Jones BE, Mansky PA, Carpenter RW (1973) Methadone - A reevaluation. Arch Gen Psychiatry 28:286-295
26. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP (1993) The effects of psychosocial services in substance a base treatment. JAMA 269:1953-1959
27. Mello NK, Mendelson JH, Bree MP, Lukasse SE (1989) Buprenorpkine suppresses cocaine self-administration by rhesus monkeys. Science 245:859-862
28. Mello NK, Mendelson JH, Bree MP, Lukas SE (1990) Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 254:926-939
29. Plunkett LM, Seifen E, Kennedy RH (1989) Effects of morphine pretreatment on cocaine cardiotoxicity in anesthetized guinea-pigs. Arch Int Pharmacodyn Ther 297:60-67
30. Preston KL, Sullivan JT, Strain EC, Bigelow GE (1992) Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 262:279-291
31. Preston KL, Sullivan JT, Berger P, Bigelow GE (1993) Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J Pharmacol Exp Ther 267:296-307
32. Shimada A, Tsuda T, Yanagita T (1988) Mode of potentiating action of cocaine in morphine analgesia. Jpn J Pharmacol 48:185-193
33. Sierra V, Duttaroy A, Lutfy K, Candido J, Billings B, Zito SW, Yoburn BC (1992) Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors. Life Sci 50: 591-597
34. Sivam SP (1989) Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 250:818-824
35. Spealman RD, Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261:607-615
36. Stitzer ML, Iguchi MY, Felch LJ (1992) Contingent take-home incentive: Effects on drug use of methadone maintenance patients. J Consult Clin Psychol 60:927-934
37. Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993) Dose-response effects of methadone in the treatment of opioid dependence. Ann Int Med 119:23-27
38. Strain EC, Preston KL, Stitzer ML, Liebson IA, Bigelow GE (1994) The effects of cocaine in buprenorphine-maintained outpatient volunteers. Am J Addict 3:129-143
39. Strug DL, Hunt DE, Goldsmith DS, Lipton DS, Spunt B (1985) Patterns of cocaine use among methadone clients. Int J Addict 20:1163-1175
40. Teoh SK, Mello NK, Mendelson JH, Kuehnle J, Gastfriend DR, Rhoades E, Sholar W (1994) Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men. J Clin Psychopharmacol 14:15-27
41. Wenger GR, Wright DW (1990) Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats. Pharmacol Biochem Behav 35:595-600
42. Willenbring ML, Morley JE, Krahn DD, Carlson GA, Levine AS, Shafer RB (1989) Psychoneuroendocrine effects of methadone maintenance. Psychoneuroendocrinology 14:371-391
43. Winger G, Skjoldager P, Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentaniland cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311-317
44. Wise RA (1988) The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 97:118-132
45. Witkin JM, Johnson RE, Jaffe JH, Goldberg SR, Grayson NA, Rice KC, Katz JL (1991) The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine. Drug Alcohol Depend 27: 177-184